SREN Swiss Re AG
Swiss Re AG, together with its subsidiaries, provides reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide. The company operates through Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions segments. The Property & Casualty Reinsurance segment underwrites property reinsurance, including property, credit, surety and political, engineering and project, aviation, marine, agriculture, renewable energy, retakaful, and facultative reinsurance solutions; and casualty reinsurance, such as liability, motor, worker's compensation, personal accident, management and professional liability, cyber, and facultative reinsurance solutions. Its Life & Health Reinsurance segment underwrites life and health insurance products. The Corporate Solutions segment offers standard risk transfer covers and multi-line programs to customized solutions. It serves stock and mutual insurance companies, public sector and governmental entities, mid-sized and large corporations, and individuals. The company was founded in 1863 and is headquartered in Zurich, Switzerland.…
Industry Peers
Insurance - ReinsuranceKey Statistics
About Swiss Re (SWX: SREN)
›
Swiss Re (SWX: SREN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Insurance - Reinsurance industry, part of the Financial Services sector, and reports about 13,806 employees.
The shares were at 147.90 CHF on 19 November 2026, up 4.0% over 52 weeks. Its 52-week range is 114.05 CHF to 160.45 CHF: the price is 7.8% below the high and 29.7% above the low.
At a market capitalisation of 43.62B CHF, it trades at 11.4 times trailing earnings and 11.6 times forward earnings. The median trailing P/E of its 12 largest Insurance - Reinsurance peers is 9.2, a premium of 24% for SREN. It pays a dividend yielding 4.17% (it pays out 49% of its earnings), against a median of 4.17% among the dividend payers in that peer group.
Swiss Re reports return on equity of 18.5%, an operating margin of 15.8% and revenue down 2.4% year over year.
Its debt exceeds its cash by 3.50B USD, a debt-to-equity ratio of 0.33. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 16 analysts cover the stock, with an average rating of Underperform; their mean price target of 131.34 CHF is 11.2% below the current price. The next earnings report is expected on 26 February 2027.